semaglutide mash approval Finally, it's officially here! ๐ฎ๐ณ 2.4 mg is now approved in India for the treatment of MASH. A significant milestone in liver care, this brings a new treatment option for ๐ดWe now have two FDA-approved
Description
The practice of microdosing GLP-1 receptor agonists is largely experimental and off-label
This may indicate inadequate caloric intake, nutritional deficiencies, or an unrelated medical condition requiring investigation
While its an effective drug, Mounjaro may be expensive, even with insurance
This simple preventive step addresses a modifiable risk factor without requiring dose adjustment or discontinuation of semaglutide or other GLP-1 compounds
Checking a chart takes five seconds
Theres no universal better side effect profile its personal
